2BB score and signals
Supernus Pharmaceuticals, Inc.’s current 2BB score is 57 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 64 | High |
| Momentum | 41 | Stable |
| Financial strength | 52 | Normal |
| Quality | 100 | Very Strong |
| Risk | 34 | Low |
Company facts
| CEO | Jack A. Khattar |
| Headquarters | Rockville, Maryland, United States |
| Founded | 2005 |
| Employees | 778 |
| 52-week range | $41.01 – $59.68 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-22 | — | 1.1067 | — | $242.66M |
| 2026-10-29 | — | 0.6273 | — | $224.63M |
| 2026-08-04 | — | 0.4284 | — | $209.06M |
| 2026-05-05 | 0.6 | 0.3035 | $207.71M | $196.78M |
Related companies
2BBBullish & Bearish